Reproductive Justice, Health & Rights
Advocates for reproductive health, rights, and justice are increasingly aware of the safety and social risks of assisted reproductive technologies and other human biotechnologies, particularly for women and children.
While assisted reproduction has helped many people create families, the long-term risks of these technologies – particularly those that require egg provision – are grossly understudied. In the U.S., assisted reproduction has developed almost entirely in the commercial sector and is notoriously underregulated.
Heritable genome editing, if allowed, would develop in this same commercial sector. Reproductive justice advocates draw attention to the risks to women and children’s health and wellbeing, the historical context of population control and reproductive oppression, and the likelihood that it would exacerbate reproductive, racial, and disability injustice.
Aggregated News
Photo from Belly of the Beast, used by permission
Yesterday, California became the third state in the nation to...
Published September 26, 2023
Emily Galpern speaks at the Black Women for Wellness Reproductive Justice Conference in August 2023 about deep disparities between the people most directly affected by state control of reproduction and those with privilege who can access privatized, high-cost fertility services to form their families.
February 8, 2022
A genetic disease runs in your family. Your doctor tells you that, should you wish to have a child, that child is likely to also carry the disease. But a new gene-editing technology could change your fate. It could ensure that your baby is -- and remains -- healthy. Even more, it could potentially make sure your grandchildren are also free of the disease. What do you do? Now, imagine it's not a rare genetic disorder, but general illness, or eye color, or cognitive ability, or athleticism. Do you opt into this new world of genetically edited humans? And what if it's not just you. What your friends, neighbors, and colleagues are also embracing this genetic revolution? Right now, science doesn't give you that choice. But huge advancements in CRISPR technology are making human gene editing a reality. In fact, in 2018, a Chinese scientist announced the first genetically modified babies; twin girls made to resist HIV, smallpox, and malaria. The promise of this technology is clear. But gene editing is not without its perils. Its critics say the technology is destined to exacerbate inequality, pressure all parents (and nations) into editing their children to stay competitive, and meddling with the most basic aspect of our humanity. In this context, we ask the question: Should we use gene editing to make better babies?
FOR THE MOTION: Dr. George Church Professor of Genetics, Harvard and MIT & Founder, Personal Genome Project; Amy Webb Futurist & Author, "The Genesis Machine"
AGAINST THE MOTION: Marcy Darnovsky, Policy Advocate; Françoise Baylis, Philosopher
Gene editing technology like CRISPR may have potential to treat diseases, but does editing future generations go too far? In this August 9, 2022 event, we heard renowned bioethicist Françoise Baylis, reproductive justice activist Nourbese Flint, and disability rights scholar and activist Karen Nakamura discuss the serious societal and ethical implications of human gene editing in the context of assisted reproductive technology. This discussion was moderated by Osagie Obasogie, professor of law and bioethics at UC Berkeley.
(For those who participated in the live event, the audio on this version has been fixed, and missing slides have been added.)
Published November 17, 2022
The prospect of using CRISPR gene editing in reproduction is often justified by claims that it will eliminate disease and disability. But these claims draw on societal narratives that devalue people with disabilities. In this roundtable conversation, Silvia Yee (Disability Rights Education and Defense Fund), Larkin Taylor-Parker (Autistic Self Advocacy Network), and Teresa Blankmeyer Burke (Gallaudet University) explore how new disability rights narratives can challenge uses of genetic and reproductive technologies based in ingrained ableism, and promote futures in which disabled people flourish. Rebecca Cokley (Ford Foundation) moderated the discussion.
Full transcript and additional information about the speakers and topic can be found on the CGS website: https://www.geneticsandsociety.org/in...
This event on November 14, 2022 was co-sponsored by Center for Genetics and Society and Disability Rights Education and Defense Fund.
Center for Genetics and Society: https://www.geneticsandsociety.org/
Disability Rights Education and Defense Fund: https://dredf.org/
Published September 21, 2022
How should we talk about equity in the context of human genome editing? While sky-high costs and lack of access to potential somatic gene therapies are important to address, we also need to ask critical questions about health equity, sovereignty, and racial justice––particularly in relation to heritable genome editing, which would alter the genes and traits of future generations. This roundtable discussion with Indigenous geneticist-bioethicist Krystal Tsosie, reproductive justice scholar and advocate Dorothy Roberts, and educator and activist Milton Reynolds addresses the legacies of eugenics, honoring Indigenous sovereignty, decolonizing DNA, and why conversations about heritable genome editing urgently need voices and perspectives grounded in social justice and human rights. This discussion was hosted by Center for Genetics and Society and moderated by CGS associate director Katie Hasson.
Access a full transcript and learn more about the event and speakers at https://www.geneticsandsociety.org/in....
Published March 31, 2023
The third panel in CGS' Missing Voices Initiative webinar series, this roundtable conversation explored the perilous prospect of reproductive uses of human genome editing from the perspective of feminist and reproductive justice scholars and advocates. Their intersectional analyses illuminated concerns related to eugenics and the rapidly expanding global fertility industry. Speakers were Kavita Ramdas, Alana Cattapan, and Amrita Pande, and the panel was moderated by Susan Berke Fogel.
Find more information about the panel's speakers here: https://www.geneticsandsociety.org/in...
Learn more about CGS' Missing Voices Initiative here: https://www.geneticsandsociety.org/in...